Comparative statistics by cancer site (ICD-10)

ICD-10: Comparative statistics by registry

Table 4: Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group


Click on country-registry for comparison

FlagCountry-registryRegistration periodNo. of casesMaleFemaleNumber of cases by age groupRelative survival by age group
5-year survival5-year survival
No.AbsRelNo.AbsRel<4545-5455-6465-7475+<4545-5455-6465-7475+
China - Hong Kong SAR 1996-200136033520.424.72550.357.82069941077015.225.525.229.535.6
China - Shangai 1992-1995372825.031.4922.224.83271690.052.131.730.035.4
China - Tianjin 1991-1999474160.473.76100.0112.33411236101.377.279.877.375.3
India - Barshi 1993-200080719.713.099822311011.413.25.313.819.4
India - Bhopal 1991-19951181031.92.31516313822110.03.53.10.00.0
India - Chennai 1990-1999101775711.914.226014.215.61722593262006021.217.213.28.94.1
India - Karunagappally 1991-199733287.79.1540.044.16317610.00.011.421.90.0
India - Mumbai 1992-19941902152217.121.238020.723.726741158745618131.119.920.223.96.7
Singapore 1993-199790849.411.463162028230.012.921.54.56.9
Republic of Korea - Busan 1996-2001878014.617.1724.524.85183421920.253.50.014.60.0
Republic of Korea - Incheon 1997-2001514925.828.82100.0121.71526154102.014.139.10.033.3
Republic of Korea - Seoul 1993-199717015924.328.71136.437.853359571640.835.024.229.038.2
Thailand - Chiang Mai 1993-1997695623.225.113031726230.033.939.414.921.1
Thailand - Lampang 1990-2000433218.320.01133.034.6231611110.067.921.429.410.7
Thailand - Songkhla 1990-199912911425.127.41548.250.94192651290.031.016.149.311.8



Graphs:


Other tables available:

- Table 1: Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site
- Table 2a: Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site
- Table 2b: Number and proportion of cases by vital status and median follow-up (in months) by site
- Table 3: Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site
- Table 4: Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group
- Table 5b: Proportion (%) of cases and 5-year absolute survival by extent of disease and site
- Table 6: Comparison of 5-year absolute and relative survival of cases diagnosed
- Table 7b: Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period
- Table 8: Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period
- Table 9: Up-to-date 10- and 15-year relative survival estimates using cohort and period approaches by site and calendar period